Research News and Research

RSS

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

Getting patients to the operating room more quickly could cut by half the amount paid for hospital treatment of painful gallstones, researchers reported today at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

A study on development of deaf children fitted with a Cochlear Implant

A multidisciplinary group at Malaga University, headed by Ignacio Moreno-Torres, is collecting information on the milestones that mark the development of deaf children fitted with a Cochlear Implant (CI) and studying to what extent the social and family environment affects this development. This research is funded with 101,000 euro by the Andalusian Regional Ministry of Innovation.

15 Oct 2009

Financial update from Gerresheimer

In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.

15 Oct 2009

Small biotechnology companies fail to attact new capital, BIO conveyes support for Investment Act of 2009

Small biotechnology companies developing new medical therapies and advanced biofuels need help attracting new capital, as investors have become especially risk averse. The Biotechnology Industry Organization (BIO) today conveyed support for the Small Business Early-Stage Investment Act of 2009, which would create a funding program at the Small Business Administration to stimulate growth in early-stage technology-based companies.

15 Oct 2009

Boehringer Ingelheim implements the iStudyReporter Bioanalytics reporting solution

Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world’s 20 leading pharmaceutical companies. Boehringer Ingelheim’s business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.

15 Oct 2009

BSA LifeStructures opens a new office in St. Louis

Architectural/engineering firm BSA LifeStructures, Inc. has opened a new office located at CityPlace in the St. Louis suburb of Creve Coeur.

15 Oct 2009

Human brains have amazing ability to be energy efficient, say researchers

Our brains, it turns out, are eco-friendly. A study published in Science and reviewed by F1000 Biology members Venkatesh Murthy and Jakob Sorensen reveals that our brains have the amazing ability to be energy efficient.

15 Oct 2009

NAHC completes BlackBerry Report

The National Association for Home Care & Hospice (NAHC) today announced the completion of The BlackBerry® Report: The National State of the Home Care Industry Study.

15 Oct 2009

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

HTDS - The issuer's Serbia based operating subsidiary Slavica BioChem www.slavicabiochem.com brings attention to its Mindup Bioresearch cancer project working on molecular origins of lung cancer: prospects for personalized prevention and therapy. On October 8 2009, the company posted a filing on Pink Sheets titled MindUp Cancer Project.

15 Oct 2009

Specific immune system cells linked to susceptibility of younger people to variant CJD

Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe.

15 Oct 2009

Genzyme ranked third on the global list for best employers

Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.

15 Oct 2009

PIKAMAB obtains U.S. patent rights to develop theragnostic product

PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it has secured exclusive rights to two issued U.S. patents from Hospital for Special Surgery, New York. PIKAMAB is developing Lupus TherasightTM, a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of lupus and lupus nephritis.

15 Oct 2009

Resveratrol in red grapes offers some protection against diabetes

A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.

15 Oct 2009

DNA Link to provide NimbleGen Sequence Capture service in Korea

Roche NimbleGen, a Roche Company, has announced the first Certified Service Provider (CSP), DNA Link, Inc., who will provide service in Korea for NimbleGen Titanium Optimized Sequence Capture coupled with services from 454 Life Sciences, Roche´s center of excellence for sequencing.

15 Oct 2009

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.

15 Oct 2009

Blue and red colored fabrics offer better protection against UV rays

Economy-minded consumers who want protection from the sun's harmful ultraviolet (UV) rays - but rather not pay premium prices for sun-protective clothing - should think blue and red, rather than yellow.

15 Oct 2009

Research to investigate and improve patient adherence to prescription drug therapies

CVS Caremark is sponsoring research to investigate patient adherence to prescription drug therapies and identify ways to increase adherence. Working with researchers from Harvard and Brigham and Women's Hospital, the company expects knowledge gained from the research will help health professionals better understand patient behavior and lead to developing programs that health care providers and pharmacies can use to improve medication adherence and ultimately help improve patient care and medical outcomes by avoiding costly hospital treatment.

15 Oct 2009

New maintenance medium for human embryonic and pluripotent stem cells

STEMCELL Technologies Inc. (STEMCELL) is pleased to announce the release of TeSR™2, a defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. This medium takes a step towards addressing the needs of researchers working towards the culture of their cells in a medium free of animal-derived proteins.

15 Oct 2009

Health reform bill approved by finance panel, Snowe sides with Democrats

Kaiser Health News staff writers Eric Pianin and Mary Agnes Carey report on yesterday's Senate Finance Committee action.

15 Oct 2009

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

Somanetics Corporation today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the agreement, Somanetics has obtained exclusive rights, subject to specified rights of the U.S. Government and rights retained by The Johns Hopkins University, to new cerebral autoregulation technology developed at The Johns Hopkins University.

15 Oct 2009

Research News and Research

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

A study on development of deaf children fitted with a Cochlear Implant

Financial update from Gerresheimer

Small biotechnology companies fail to attact new capital, BIO conveyes support for Investment Act of 2009

Boehringer Ingelheim implements the iStudyReporter Bioanalytics reporting solution

BSA LifeStructures opens a new office in St. Louis

Human brains have amazing ability to be energy efficient, say researchers

NAHC completes BlackBerry Report

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

Specific immune system cells linked to susceptibility of younger people to variant CJD

Genzyme ranked third on the global list for best employers

PIKAMAB obtains U.S. patent rights to develop theragnostic product

Resveratrol in red grapes offers some protection against diabetes

DNA Link to provide NimbleGen Sequence Capture service in Korea

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

Blue and red colored fabrics offer better protection against UV rays

Research to investigate and improve patient adherence to prescription drug therapies

New maintenance medium for human embryonic and pluripotent stem cells

Health reform bill approved by finance panel, Snowe sides with Democrats

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms